The inflammation from NLRP3 inflammasome activation plays a crucial role in many metabolic diseases including NAFLD, and our animal experiments showed that Man inhibits NLRP3-mediated inflammation and pyroptosis in hepatocytes by western blot and RNA-seq analysis. Here, NLRP3 is linked to metabolic disease.